--- title: "Pfizer climbs 3% as Q3 results beat estimates and guidance raised" type: "News" locale: "en" url: "https://longbridge.com/en/news/304295294.md" description: "Pfizer rose 2.57% to $30.77 as Q3 revenue beat estimates and full-year EPS guidance was raised to $2.95–$3.05." datetime: "2026-11-04T14:33:17.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/304295294.md) - [en](https://longbridge.com/en/news/304295294.md) - [zh-HK](https://longbridge.com/zh-HK/news/304295294.md) generator: "portal-rs" --- # Pfizer climbs 3% as Q3 results beat estimates and guidance raised Pfizer (PFE.US) climbed nearly **3%** during regular trading to **$30.77**. The pharmaceuticals industry index rose 2.4% over the same period. The company reported fiscal third-quarter revenue of **$16.58 billion**, topping the analyst consensus of **$15.87 billion**. Adjusted earnings per share came in at **$0.87**, beating estimates of **$0.73**. Operational revenue grew 7% excluding Covid-19 products, while sales from launched and acquired non-Covid assets surged 32%. Pfizer raised its full-year revenue guidance to **$62.0 billion to $64.0 billion** and adjusted EPS outlook to **$2.95 to $3.05**, up from prior ranges of $60.5 billion to $62.5 billion and $2.80 to $3.00, respectively. Citi raised its price target on Pfizer to $30 from $27, while RBC increased its target to $28 from $25. Management said on the earnings call that cost savings will be reinvested into R&D with a focus on oncology and obesity pipelines, targeting approval for a monthly weight-loss injection by 2028. Nearly all of the expected $7.2 billion in net savings are on track to be realized by end-2026. Based on public media reports. AI-generated; not investment advice. ### Related Stocks - [PFE.US](https://longbridge.com/en/quote/PFE.US.md) ## Related News & Research - [Pfizer inks $2.6bn autoimmune deal with China’s Starna for CAR-T therapies](https://longbridge.com/en/news/306119677.md) - [Blackstone backs Pfizer’s obesity ambitions with $1.5bn fund](https://longbridge.com/en/news/305354338.md) - [Wall St Week Ahead-'Black Friday' brings consumer spending into focus for AI-rocked market](https://longbridge.com/en/news/306395310.md) - [Jabil (JBL) Heads Into Earnings As Its AI Narrative Keeps Undervalued View Alive](https://longbridge.com/en/news/306391907.md) - [Kevin O’Leary declared 'inflation affects all of us' while shopping for Walmart paper towel bargains. How to fight back](https://longbridge.com/en/news/306393334.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**